Na-ATP drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Na-ATP | associated_with | basolateral amygdala | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Increasing the GluN2A/GluN2B Ratio in Neurons of the Mouse Basal and Lateral Amygdala Inhibits the Modification of an Existing Fear Memory Trace. (2016)
- Modeling hippocampal neurogenesis using human pluripotent stem cells. (2014)
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. (2013)
- Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. (2013)
- Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. (2009)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| na-atp | drug | 4 | 4 |
| sodium atp | drug | 1 | 1 |